SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Securities Fraud Violat...
May 27 2016 - 2:46PM
Business Wire
Levi & Korsinsky announces it has commenced an investigation
of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ:BIIB) concerning
possible violations of federal securities laws.
In an April 21, 2016 SEC filing, Biogen acknowledged receipt of
a subpoena from the federal government requesting documents related
to the Company’s relationship with non-profit organizations that
provide assistance to patients taking drugs sold by the Company. On
May 27, 2016, Bloomberg reported that Biogen is one of three major
drugmakers to disclose in a recent SEC filing the receipt of a
subpoena as part of this expanding federal investigation. To obtain
additional information about the investigation, go to:
http://zlk.9nl.com/biib
or contact Eduard Korsinsky, Esq. either via email at ek@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation involving financial
fraud, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160527005773/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Sep 2023 to Sep 2024